Montalescot, Gilles <br/><br/>
Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial.  [electronic resource] 

 -  Lancet (London, England)  Aug 2011 
 - 693-703 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-547X 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(11)60876-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angioplasty, Balloon, Coronary<br/>Anticoagulants--administration & dosage<br/>Electrocardiography<br/>Enoxaparin--administration & dosage<br/>Female<br/>Fibrinolytic Agents--administration & dosage<br/>Heparin--administration & dosage<br/>Humans<br/>Injections, Intravenous<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--mortality<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Recurrence